NII Holdings (NASDAQ:NIHD) was downgraded by analysts at Gabelli from a “hold” rating to a “sell” rating in a research report issued to clients and investors on Wednesday, TheFlyOnTheWall.com reports. NII Holdings Inc. (NASDAQ:NIHD) net profit margin is -34.60% and weekly performance is -14.29%. On last trading day company shares ended up $0.600. Analysts mean target price for the company is $2.04. NII Holdings Inc. (NASDAQ:NIHD) distance from 50-day simple moving average (SMA50) is -39.36%.
Majesco Entertainment Company (NASDAQ:COOL), an innovative provider of video games for the mass market, and Focus Home Interactive, announced that Bound by Flame on PlayStation(R) 4 computer entertainment system, PlayStation(R) 3 computer entertainment system and the Xbox 360 games and entertainment system from Microsoft is on store shelves in North America. Majesco Entertainment Co. (NASDAQ:COOL) shares fell -2.11% in last trading session and ended the day on $0.372. COOL gross Margin is 18.40% and its return on assets is -45.20%.Majesco Entertainment Co. (NASDAQ:COOL) quarterly performance is -32.36%.
Ford Motor Company (NYSE:F) had a big presence at last month’s New York International Auto Show. Ford celebrated the 50th anniversary of the original Mustang’s debut by unveiling a commemorative model — and with an epic stunt at the Empire State Building. The company also showed off its refreshed-for-2015 Focus, and many key Ford executives were on hand. Those executives included Ford’s Chief Operating Officer, Mark Fields. Fields opened the New York show’s media days with a keynote speech that framed the show as a showcase of innovation. Ford Motor Company (NYSE:F) shares moved up 0.45% in last trading session and was closed at $15.76, while trading in range of $15.56 – $15.86. Ford Motor Company (NYSE:F) year to date (YTD) performance is 3.75%.
MEI Pharma, Inc. (NASDAQ:MEIP), an oncology company focused on the clinical development of novel therapies for cancer, announced that the first patient has been dosed in a Phase Ib clinical study of its investigational mitochondrial inhibitor drug candidate ME-344 in combination with Hycamtin® (topotecan) in patients with solid tumors, including small cell lung and ovarian cancers. The open-label study is expected to enroll up to 64 patients with preliminary data anticipated by the first quarter of 2015. MEI Pharma Inc. (NASDAQ:MEIP) ended the last trading day at $6.06. Company weekly volatility is calculated as 11.01% and price to cash ratio as 2.19.MEI Pharma Inc. (NASDAQ:MEIP) showed a negative weekly performance of -12.43%.
Qunar Cayman Islands Ltd (NASDAQ:QUNR) reported ($0.27) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.12) by $0.15. The company had revenue of $54.00 million for the quarter, compared to the consensus estimate of $50.06 million. Qunar Cayman Islands Ltd (NASDAQ:QUNR) net profit margin is -13.50% and weekly performance is -11.15%. On last trading day company shares ended up $22.16. Analysts mean target price for the company is $36.71. Qunar Cayman Islands Ltd (NASDAQ:QUNR) distance from 50-day simple moving average (SMA50) is -22.65%.